Cargando…
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS progr...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699707/ https://www.ncbi.nlm.nih.gov/pubmed/23689796 http://dx.doi.org/10.1007/s00125-013-2928-7 |
_version_ | 1782275442804260864 |
---|---|
author | Looker, H. C. Nyangoma, S. O. Cromie, D. T. Olson, J. A. Leese, G. P. Philip, S. Black, M. W. Doig, J. Lee, N. Briggs, A. Hothersall, E. J. Morris, A. D. Lindsay, R. S. McKnight, J. A. Pearson, D. W. M. Sattar, N. A. Wild, S. H. McKeigue, P. Colhoun, H. M. |
author_facet | Looker, H. C. Nyangoma, S. O. Cromie, D. T. Olson, J. A. Leese, G. P. Philip, S. Black, M. W. Doig, J. Lee, N. Briggs, A. Hothersall, E. J. Morris, A. D. Lindsay, R. S. McKnight, J. A. Pearson, D. W. M. Sattar, N. A. Wild, S. H. McKeigue, P. Colhoun, H. M. |
author_sort | Looker, H. C. |
collection | PubMed |
description | AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS programme collected between 2005 and 2011 for people aged ≥12 years with type 1 or type 2 diabetes in Scotland. We used hidden Markov models to calculate the probabilities of transitions to referable diabetic retinopathy (referable background or proliferative retinopathy) or referable maculopathy. RESULTS: The study included 155,114 individuals with no referable diabetic retinopathy or maculopathy at their first DRS examination and with one or more further DRS examinations. There were 11,275 incident cases of referable diabetic eye disease (9,204 referable maculopathy, 2,071 referable background or proliferative retinopathy). The observed transitions to referable background or proliferative retinopathy were lower for people with no visible retinopathy vs mild background retinopathy at their prior examination (respectively, 1.2% vs 8.1% for type 1 diabetes and 0.6% vs 5.1% for type 2 diabetes). The lowest probability for transitioning to referable background or proliferative retinopathy was among people with two consecutive screens showing no visible retinopathy, where the probability was <0.3% for type 1 and <0.2% for type 2 diabetes at 2 years. CONCLUSIONS/INTERPRETATION: Transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and two consecutive screens showing no visible retinopathy. If such people had been offered two yearly screening the DRS service would have needed to screen 40% fewer people in 2009. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-013-2928-7) contains peer reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-3699707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-36997072013-08-05 Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme Looker, H. C. Nyangoma, S. O. Cromie, D. T. Olson, J. A. Leese, G. P. Philip, S. Black, M. W. Doig, J. Lee, N. Briggs, A. Hothersall, E. J. Morris, A. D. Lindsay, R. S. McKnight, J. A. Pearson, D. W. M. Sattar, N. A. Wild, S. H. McKeigue, P. Colhoun, H. M. Diabetologia Article AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS programme collected between 2005 and 2011 for people aged ≥12 years with type 1 or type 2 diabetes in Scotland. We used hidden Markov models to calculate the probabilities of transitions to referable diabetic retinopathy (referable background or proliferative retinopathy) or referable maculopathy. RESULTS: The study included 155,114 individuals with no referable diabetic retinopathy or maculopathy at their first DRS examination and with one or more further DRS examinations. There were 11,275 incident cases of referable diabetic eye disease (9,204 referable maculopathy, 2,071 referable background or proliferative retinopathy). The observed transitions to referable background or proliferative retinopathy were lower for people with no visible retinopathy vs mild background retinopathy at their prior examination (respectively, 1.2% vs 8.1% for type 1 diabetes and 0.6% vs 5.1% for type 2 diabetes). The lowest probability for transitioning to referable background or proliferative retinopathy was among people with two consecutive screens showing no visible retinopathy, where the probability was <0.3% for type 1 and <0.2% for type 2 diabetes at 2 years. CONCLUSIONS/INTERPRETATION: Transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and two consecutive screens showing no visible retinopathy. If such people had been offered two yearly screening the DRS service would have needed to screen 40% fewer people in 2009. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-013-2928-7) contains peer reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2013-05-21 2013 /pmc/articles/PMC3699707/ /pubmed/23689796 http://dx.doi.org/10.1007/s00125-013-2928-7 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Article Looker, H. C. Nyangoma, S. O. Cromie, D. T. Olson, J. A. Leese, G. P. Philip, S. Black, M. W. Doig, J. Lee, N. Briggs, A. Hothersall, E. J. Morris, A. D. Lindsay, R. S. McKnight, J. A. Pearson, D. W. M. Sattar, N. A. Wild, S. H. McKeigue, P. Colhoun, H. M. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme |
title | Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme |
title_full | Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme |
title_fullStr | Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme |
title_full_unstemmed | Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme |
title_short | Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme |
title_sort | predicted impact of extending the screening interval for diabetic retinopathy: the scottish diabetic retinopathy screening programme |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699707/ https://www.ncbi.nlm.nih.gov/pubmed/23689796 http://dx.doi.org/10.1007/s00125-013-2928-7 |
work_keys_str_mv | AT lookerhc predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT nyangomaso predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT cromiedt predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT olsonja predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT leesegp predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT philips predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT blackmw predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT doigj predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT leen predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT briggsa predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT hothersallej predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT morrisad predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT lindsayrs predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT mcknightja predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT pearsondwm predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT sattarna predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT wildsh predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT mckeiguep predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT colhounhm predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme AT predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme |